GO:0036454 growth factor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036454 (growth factor complex) is a cellular component defined as a protein complex that has growth factor activity.
• Growth factor complexes assemble from secreted growth factor ligands and their binding partners, often in the extracellular matrix or on cell surfaces.
• They activate signaling pathways such as RAS-MAPK, PI3K-AKT, and mTORC1 to control cell cycle progression, survival, and differentiation.
• Dysregulated growth factor complexes drive cancer, fibrosis, and impaired tissue repair, making them key therapeutic targets.
• Experimental models include knockout, point-mutation, knock-in, and overexpression cell lines to dissect complex assembly and function.
• EDITGENE provides CRISPR services for studying growth factor complex components, from library screening to bioinformatics.
Description
GO:0036454, growth factor complex, is a Gene Ontology cellular component term that describes a protein complex with growth factor activity. Growth factors are secreted signaling molecules that regulate fundamental cellular processes including proliferation, survival, migration, and differentiation. Unlike single growth factor polypeptides, a growth factor complex comprises multiple subunits that together form a functional signaling unit, often stabilized by extracellular matrix interactions or binding proteins. Understanding these complexes is critical because their dysregulation underlies numerous diseases, from cancer to chronic wounds. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of growth factor complex biology, its components, mechanisms, and experimental approaches for studying it.
growth factor complex At A Glance
| GO ID | GO:0036454 |
|---|---|
| GO term | growth factor complex |
| Ontology | cellular_component |
| Synonym | None |
| Definition | A protein complex that has growth factor activity. |
| Major function | Stimulates cell proliferation, survival, and differentiation through receptor-mediated signaling. |
| Related processes | Cell cycle progression, wound healing, tissue regeneration, mTORC1 signaling. |
| Cellular location | Extracellular space, extracellular matrix, cell surface. |
| Example components | Growth factor ligands (e.g., IGF1, FGF2), binding proteins (e.g., IGFBP3), matrix proteins. |
What Is GO:0036454?
According to the Gene Ontology, GO:0036454 (growth factor complex) is a protein complex that has growth factor activity. This means the complex as a whole can stimulate cellular growth, proliferation, or differentiation by binding to specific receptors on target cells. The term falls under the cellular component ontology, indicating it describes a physical assembly of proteins rather than a process or molecular function. Growth factor complexes may include the growth factor ligand itself, binding proteins that modulate its activity, and structural components that localize the complex to the extracellular matrix or cell surface.
Why Is growth factor complex Important in Cell Biology?
Growth factor complexes are central to intercellular communication and tissue homeostasis. They integrate signals from the extracellular environment to control cell fate decisions, and their malfunction contributes to cancer, fibrosis, chronic wounds, and developmental disorders. Studying these complexes helps identify therapeutic targets and biomarkers, and enables the development of regenerative medicine strategies.
• Regulate cell cycle progression and proliferation.
• Control cell survival and apoptosis through redox-sensitive pathways.
• Coordinate wound healing and tissue repair.
• Modulate stem cell self-renewal and differentiation.
• Drive angiogenesis and extracellular matrix remodeling.
• Implicated in cancer progression and metastasis.
• Targeted in musculoskeletal disorders and regenerative therapies.
• Involved in dentin-pulp complex regeneration.
• Linked to metabolic regulation via mTORC1 signaling.
• Serve as biomarkers for disease diagnosis and prognosis.
Core Biology of growth factor complex (GO:0036454)
Assembly and Secretion
In simple terms: Growth factor complexes are built inside cells and then released outside to send signals.
Growth factor complexes assemble in the endoplasmic reticulum and Golgi apparatus, where growth factor ligands fold and associate with binding proteins or matrix components. Secretion delivers the complex to the extracellular space, where it can act on target cells. For example, insulin-like growth factors (IGFs) form complexes with IGF-binding proteins (IGFBPs), which modulate their half-life and receptor accessibility. The assembly process is tightly regulated to ensure proper stoichiometry and activity.
Extracellular Matrix Interactions
In simple terms: The extracellular matrix acts like a scaffold that holds growth factor complexes in place.
Many growth factor complexes bind to extracellular matrix (ECM) components such as heparan sulfate proteoglycans, which sequester and present them to receptors. This interaction creates a localized reservoir of growth factors, allowing precise spatial and temporal control of signaling. ECM binding can also protect growth factors from degradation and enhance their activity.
Receptor Activation and Signal Transduction
In simple terms: When a growth factor complex binds to its receptor, it flips a switch that tells the cell to grow or survive.
Upon binding to cell surface receptors (e.g., receptor tyrosine kinases), growth factor complexes induce receptor dimerization and autophosphorylation, initiating downstream signaling cascades such as RAS-MAPK, PI3K-AKT, and mTORC1. These pathways regulate gene expression, metabolism, and cell cycle progression. The duration and strength of signaling are modulated by feedback loops and crosstalk with other pathways.
Regulation by Binding Proteins and Redox State
In simple terms: Helper proteins and the cell's oxidation balance can turn growth factor signals up or down.
Growth factor activity is fine-tuned by binding proteins (e.g., IGFBP3) that can either inhibit or enhance signaling. Redox conditions also regulate growth factor survival signaling; reactive oxygen species can modify signaling proteins and affect complex stability. This layer of regulation ensures appropriate responses to environmental cues.
Key Genes Involved in GO:0036454 growth factor complex
The following genes encode proteins that are components or regulators of growth factor complexes, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IGF1 | Growth factor ligand | Mediates growth and survival; studied in growth disorders |
| IGF2 | Growth factor ligand | Implicated in cancer and overgrowth syndromes |
| IGFBP3 | Binding protein | Modulates IGF bioavailability; linked to cancer |
| FGF2 | Growth factor ligand | Promotes angiogenesis and wound healing |
| VEGFA | Growth factor ligand | Key regulator of angiogenesis |
| PDGFB | Growth factor ligand | Drives fibroblast proliferation in fibrosis |
| EGF | Growth factor ligand | Stimulates epithelial cell proliferation |
| TGFB1 | Growth factor ligand | Regulates ECM deposition and immune response |
| HGF | Growth factor ligand | Promotes cell motility and morphogenesis |
| IGF1R | Receptor | Mediates IGF signaling; target in cancer |
| FGFR1 | Receptor | Transduces FGF signals; involved in development |
| EGFR | Receptor | Oncogene; target of cancer therapies |
| KDR | Receptor | VEGF receptor; regulates angiogenesis |
| TSC1 | Signaling regulator | Integrates growth factor signals to mTORC1 |
| TSC2 | Signaling regulator | Integrates growth factor signals to mTORC1 |
| AKT1 | Signaling kinase | Survival signaling downstream of growth factors |
| MAPK1 | Signaling kinase | Proliferation signaling downstream of growth factors |
How Is growth factor complex Regulated?
Growth factor complex activity is regulated at multiple levels. Transcription and translation control the availability of ligands and binding proteins. Secretion and ECM binding determine local concentration and presentation. Receptor availability and post-translational modifications modulate sensitivity. Intracellular feedback loops, including mTORC1 and redox-sensitive pathways, adjust signaling strength and duration. Binding proteins such as IGFBP3 can inhibit or potentiate growth factor action.
growth factor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IGF1 | Growth hormone insensitivity, growth failure | Knockout mouse, patient-derived iPSCs |
| IGF2 | Beckwith-Wiedemann syndrome, cancer | Overexpression cell lines, knock-in models |
| EGFR | Non-small cell lung cancer, glioblastoma | Point-mutation knock-in (e.g., L858R), KO |
| VEGFA | Age-related macular degeneration, cancer | Knockout, overexpression |
| TSC1/TSC2 | Tuberous sclerosis complex | Knockout cell lines, patient mutations |
Cancer
Dysregulated growth factor complexes drive uncontrolled proliferation and survival in many cancers. Overexpression of growth factors like IGF2 and VEGF promotes tumor growth and angiogenesis. Mutations in receptors such as EGFR and IGF1R lead to constitutive signaling. Targeting these complexes with inhibitors or antibodies is a major therapeutic strategy.
Chronic Wounds and Fibrosis
Impaired growth factor complex function contributes to chronic non-healing wounds, while excessive signaling leads to fibrosis. TGFB1 complexes promote ECM deposition and scarring. Therapeutic modulation of growth factor complexes is being explored for wound healing and fibrotic diseases.
Metabolic and Growth Disorders
Disorders of growth factor complexes include insulin-like growth factor deficiency and resistance, leading to growth failure. Mecasermin rinfabate, a complex of IGF1 and IGFBP3, is used to treat severe IGF1 deficiency. Dysregulation of mTORC1 signaling downstream of growth factors is implicated in metabolic diseases.
From growth factor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IGF1 complex impair growth? | IGF1 knockout cell line or mouse |
| How do point mutations in EGFR affect signaling? | EGFR point-mutation knock-in cell line |
| Can we tag endogenous growth factor complexes for imaging? | Knock-in of fluorescent tag (e.g., GFP) |
| What is the effect of growth factor overexpression? | Overexpression cell line via lentiviral transduction |
| Which genes regulate growth factor complex assembly? | CRISPR library screening |
| How does ECM binding affect growth factor activity? | 3D culture models with ECM components |
How to Study the growth factor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| AP-MS | Protein-protein interactions | Identifying growth factor complex components |
| CRISPR knockout screening | Gene function loss | Discovering regulators of growth factor signaling |
| RNA-seq | Gene expression | Profiling growth factor and receptor expression |
| Phosphoproteomics | Signaling activation | Mapping downstream pathways |
| Live-cell imaging | Complex dynamics | Visualizing secretion and receptor binding |
| ELISA | Protein quantification | Measuring growth factor levels in samples |
| Bioinformatics pathway analysis | Functional enrichment | Interpreting omics data in GO context |
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify components of growth factor complexes and their post-translational modifications. Affinity purification followed by mass spectrometry (AP-MS) reveals interacting partners and assembly dynamics.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate growth factor complex function or downstream signaling. These screens are powerful for discovering novel regulators and therapeutic targets.
Imaging and Live-Cell Analysis
Fluorescence microscopy with tagged growth factors or receptors allows visualization of complex assembly, secretion, and receptor binding in real time. FRET and BRET biosensors can monitor signaling dynamics.
Transcriptomics and Bioinformatics
RNA-seq and single-cell transcriptomics reveal expression patterns of growth factor complex components across tissues and conditions. Bioinformatics integration with pathway databases (e.g., GO, Reactome) provides functional context.
How CRISPR Can Be Used to Study GO:0036454 growth factor complex
Knockout
CRISPR knockout of genes encoding growth factor complex components (e.g., IGF1, VEGFA) ablates complex formation and signaling, revealing essential functions in proliferation, survival, and development. Knockout cell lines are valuable for drug target validation.
Point Mutation
Point mutations can mimic disease-associated variants in growth factor receptors (e.g., EGFR L858R) or ligands, allowing study of constitutive activation or loss of binding. These models are crucial for understanding oncogenic mechanisms and testing targeted therapies.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into endogenous loci enables tracking of growth factor complex expression, localization, and dynamics without overexpression artifacts. Knock-in of disease mutations creates isogenic models for functional studies.
Overexpression
Overexpression of growth factors or their receptors (e.g., IGF2, EGFR) via lentiviral or transgenic systems models gain-of-function states seen in cancer and other diseases. These models help identify downstream effectors and resistance mechanisms.
How EDITGENE Supports growth factor complex Research
Researchers studying growth factor complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation and therapeutic target discovery.
Contact EDITGENE today to design your custom CRISPR model for growth factor complex research.
Frequently Asked Questions About growth factor complex
What is GO:0036454?
GO:0036454 is the Gene Ontology term for growth factor complex, a protein complex that has growth factor activity.
What genes are involved in growth factor complex?
Genes include IGF1, IGF2, IGFBP3, FGF2, VEGFA, PDGFB, EGF, TGFB1, HGF, and their receptors such as IGF1R, FGFR1, EGFR, and KDR.
What is the function of growth factor complex?
It stimulates cell proliferation, survival, differentiation, and migration by activating signaling pathways like RAS-MAPK, PI3K-AKT, and mTORC1.
How is growth factor complex regulated?
It is regulated by transcription, secretion, ECM binding, binding proteins, receptor availability, and feedback loops including redox and mTORC1 signaling.
What diseases are associated with growth factor complex dysfunction?
Cancer, chronic wounds, fibrosis, growth disorders, and metabolic diseases.
How can I study growth factor complex in the lab?
Use CRISPR knockout, point mutation, knock-in, overexpression models, proteomics, imaging, and CRISPR screening.
What is the role of IGFBP3 in growth factor complex?
IGFBP3 binds IGF1 and IGF2, modulating their bioavailability and activity, and is implicated in cancer and growth regulation.
Can CRISPR be used to model growth factor complex diseases?
Yes, CRISPR enables creation of knockout, point-mutation, knock-in, and overexpression models to study disease mechanisms and test therapies.
What is the connection between growth factor complex and mTORC1?
Growth factor signaling activates mTORC1 through TSC1/TSC2, regulating cell growth and metabolism.
How does the extracellular matrix interact with growth factor complex?
ECM components bind and sequester growth factors, presenting them to receptors and modulating signaling.
Conclusion
GO:0036454 (growth factor complex) represents a critical cellular component that orchestrates diverse signaling events essential for normal development and tissue homeostasis. Its dysfunction is implicated in cancer, fibrosis, and metabolic disorders, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches continue to unravel the complexities of growth factor complex assembly and regulation, offering new opportunities for drug discovery and regenerative medicine.
References
- 1. Wang K et al.. 2025. Evolution of growth factor signaling to the TSC complex to regulate mTORC1.. Sci Signal 18(894):eadw4165 PMID: 40627686
- 2. Wang Z. 2021. Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.. Cells 10(12) PMID: 34943835
- 3. Li Z et al.. 2021. The effects and potential applications of concentrated growth factor in dentin-pulp complex regeneration.. Stem Cell Res Ther 12(1):357 PMID: 34147130
- 4. Barrientos S et al.. 2008. Growth factors and cytokines in wound healing.. Wound Repair Regen 16(5):585-601 PMID: 19128254
- 5. Hynes RO. 2009. The extracellular matrix: not just pretty fibrils.. Science 326(5957):1216-9 PMID: 19965464
- 6. Pearson JJ et al.. 2022. Growth Factor Immobilization Strategies for Musculoskeletal Disorders.. Curr Osteoporos Rep 20(1):13-25 PMID: 35118607
- 7. Woolley JF et al.. 2013. Redox-regulated growth factor survival signaling.. Antioxid Redox Signal 19(15):1815-27 PMID: 23198948
- 8. Kemp SF. 2007. Mecasermin rinfabate.. Drugs Today (Barc) 43(3):149-55 PMID: 17380212
